Abstract:
A solid foundation for assessing asthma management is provided by demographic analyses of
asthma conditions and medication use in a community. The purpose of this study is to identify risk
factors among patients in addition to the medical care recommended by doctors in the heart of
Brahmanbaria, Bangladesh. Asthma sufferers' monotherapy and combination therapies are
highlighted in this treatment section along with various therapeutic classes. This investigation was
carried out in a number of notable secondary-level hospitals in the Brahmanbaria city. The patients
were questioned regarding the duration of the illnesses they were suffering from, possible causes
of asthma development, and prescription regimen. Extrinsic asthma affects 63% of individuals,
while intrinsic asthma affects 37% of patients. It was discovered that 34 people smoke actively, 59
people smoke passively around their family, and 7 people smoke completely consciously. In the
other hand, Patients who have had the condition for 6 to 12 months make up 43%. The majority of
patients—56%—have complained of chest discomfort. 28% of people wheeze while breathing.
Here are the total 100 patients where 15% have been prescribed salbutamol. Mostly prescribed
monotherapy was given with LTRA in 23% of patients. 11% of patients have been prescribed
inhaled corticosteroids budesonide. Loratadine was rarely used in 2% of patients. LTRA and
Doxofylline combination had a prevalence of 31% which was the maximum. In the case of severe
persistent asthma, 8% of patients had been prescribed formoterol ipratropium bromide and
budesonide combination.
